Biobanking Market: How Is the Cell and Gene Therapy Pipeline...

added blog Botanik

2026-05-16 09:19:22

Biobanking Market: How Is the Cell and Gene Therapy Pipeline Transforming Biobanking Requirements?

Cell and gene therapy's biobanking revolution — the requirement for long-term cryogenic preservation of autologous patient cells (leukapheresis products for CAR-T manufacturing), allogeneic starting materials (iPSC-derived cell therapy banks, NK cell banks), viral vectors (AAV and lentiviral vector GMP banks), and clinical trial reference samples creating a new class of high-value,...

0 Comments 0 Shares 12 Views 0 Reviews